about
Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeAutologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.Immunotherapy of brain cancers: the past, the present, and future directions.Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumorsAntitumor cytotoxic T-cell response induced by a survivin peptide mimicDendritic cell vaccination in glioblastoma after fluorescence-guided resectionCell-based immunotherapy against gliomas: from bench to bedsideExpression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma.Medulloblasoma: challenges for effective immunotherapy.Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Immune and viral therapies for malignant primary brain tumors.Engineering challenges for brain tumor immunotherapy.miR-181d regulates human dendritic cell maturation through NF-κB pathway.Immunomodulatory effects of hemagglutinin- (HA-) modified A20 B-cell lymphoma expanded as a brain tumor on adoptively transferred HA-Specific CD4+ T cells.
P2860
Q28087485-BB932DBB-0B4B-40F0-9AF8-9CA0975AD079Q33600115-6B4847D8-4FB5-457B-8939-565A93DF9C4FQ34287535-4D1F778B-151C-400F-9D8C-42A1A5D77AAFQ34407938-153169E2-960E-4151-AF03-A06FADB94B8FQ34533616-1AAD75F2-E1AE-4F0B-B981-7B41BF835F90Q34701587-5D0532E4-5BE3-4C66-8A85-FFB91C271103Q35962460-0B5CDDB3-F442-44D1-88F7-8FD6BFF1E5CEQ36155913-F716C9FB-B771-4984-9530-76042D948ACDQ36507978-198717B3-9717-4EE4-9FF9-A9C9752EC9AEQ36984482-D248D578-5A5A-4534-8CFC-DFA47D6C286BQ37579001-CAFC77CF-0E68-420E-86EB-01DA803D45DFQ37968929-D3B79C35-7565-4654-80E3-A689A1C5F1FBQ38063583-9E4C2B41-9C32-4DBF-817B-19341F1405C0Q38223605-4BDD31CD-4B8A-4128-9318-5607EAA2FB2BQ38526550-4882E5A0-7F9F-44A9-9601-9A6814D6EF7EQ38912265-4803B9CB-384F-4613-9A72-26889750E4C7Q39168899-4C26B031-A3BF-4392-86F0-96C4B7123D64Q39381281-FA0BB807-E6E4-4D6B-BBCD-2E75A422D10CQ47821872-4C8D0E47-709D-4221-8C47-01D79EFB7AC7Q53584094-0662E12D-0580-48AB-B6C2-3DA1390FE930
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dendritic cell vaccines for brain tumors
@ast
Dendritic cell vaccines for brain tumors
@en
Dendritic cell vaccines for brain tumors
@nl
type
label
Dendritic cell vaccines for brain tumors
@ast
Dendritic cell vaccines for brain tumors
@en
Dendritic cell vaccines for brain tumors
@nl
prefLabel
Dendritic cell vaccines for brain tumors
@ast
Dendritic cell vaccines for brain tumors
@en
Dendritic cell vaccines for brain tumors
@nl
P2860
P1476
Dendritic cell vaccines for brain tumors
@en
P2093
Linda M Liau
P2860
P304
P356
10.1016/J.NEC.2009.09.005
P407
P577
2010-01-01T00:00:00Z